We previously demonstrated that LYPLAL1-DT acts as a molecular sponge for miR-204-5p, leading to the upregulation of BCL2 and consequent inhibition of chemotherapy-induced apoptosis in SCLC. Here, LYPLAL1 is linked to small cell lung carcinoma.